50
DAFTAR PUSTAKA
1. Wells B, Dipiro J, Matzke G, Posey L, Schwinghammer T. Pharmacotherapy Handbook. 7th ed. New York, USA: McGraw-Hill Professional Publishing; 2009.
2. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia 9PERKI). Pedoman Tatalaksana Hipertensi pada Penyakit Kardiovaskular. Jakarta: Centra Communication; 2015;
3. Alfian R, Susanto Y, Khadizah S. Kualitas hidup pasien hipertensi dengan penyakit penyerta di poli jantung RSUD Ratu Zalecha Martapura. Pharmascience. 2017;04(01):39–47.
4. Giles TD, Materson BJ, Cohn JN, Kostis JB. Definition and classification of hypertension: An update. J Clin Hypertens. 2009;11(11):611–4.
5. Yonata A, Satria A, Pratama P. Hipertensi sebagai faktor pencetus terjadinya stroke majority. 2016;5(3):17.
6. Siringoringo M, Hiswani, Jemadi. Faktor- faktor yang berhubungan dengan hipertensi pada lansia di desa sigaol simbolon kabupaten samosir tahun 2013. 2013;62(1):1–6.
7. Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. Riset kesehatan dasar. Jakarta; 2013.
8. RI PD dan IKK. Infodatin. Jakarta; 2014.
9. Dinas Kesehatan Kota Padang. Profil Kesehatan Kota Padang. Profil Kesehatan Kota Padang. Padang; 2017.
10. WHO. A Global Brief On Hypertension. Switzerland: WHO Press; 2013. 11. Sinuraya RK, Siagian BJ, Taufik A, Destiani DP, Puspitasari IM, Lestari K,
et al. Assessment of Knowledge on Hypertension among Hypertensive Patients in Bandung City: A Preliminary Study.
12. Tyashapsari M, Zulkarnain A. Penggunaan Obat Pada Pasien Hipertensi Di Instalasi Rawat Ianp Rumah Sakit Umum Pusat Dr. Kariadi Semarang. J Clin Hypertens. 2012;8(2):145–51.
13. Chobanian A V., Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.
51
14. Untari MK, Nugroho AE, Irijanto F. Perbandingan Efek Terapi Kombinasi 2 Obat Dengan 3 Obat Antihipertensi Pada Pasien Hemodialisis. J Manaj dan Pelayanan Farm. 2014;4(4):213–8.
15. Doi M, Miyoshi T, Hirohata S, Kamikawa S, Usui S, Kaji Y, et al. Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients. 16. Sulistyarini I. Terapi Relaksasi untuk Menurunkan Tekanan Darah dan
Meningkatkan Kualitas Hidup Penderita Hipertensi. J Psikol 2013;40(1):28–38.
17. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and Evaluation of the Kansas City Cardiomyopathy Questionnaire: A New Health Status Measure for Heart Failure. J Am Coll Cardiol 18. Polikandrioti M. Health Failure and Health Related Quality of Life. Heal Sci J. 2008;2(3):119–20.
19. Sari A, Lestari NY, Perwitasari DA. Validasi ST European Quality Of Life-5 Dimensions (EQ-Life-5D) Versi Indonesia Pada Pasien Hipertensi Di Puskesmas Kotagede II Yogyakarta. Pharmaciana. 2015;5(2):131.
20. Horowitz E, Abadi-Korek I, Shani M, Shemer J. EQ-5D as a Generic Measure of Health-Related quality of Life in Israel: Reability, Validity and Responsiveness. Isr Med Assoc J. 2010;12(12):715–20.
21. Reenen M van, Oppe M. EQ-5D-3L User Guide: Basic Information On How to Use The EQ-5D-3L Instrument. EuroQol Res Found. 2015;(April):22.
22. Annisa. Penilaian Kualitas Hidup Pada Usia Lanjut dengan menggunakan EQ-5D di Klub Jantung Sehat Pondok Kelapa. 2013;
23. Adler M, Carvalho N, Bispo I, Silva S, Brito S, Ramos P, et al. Quality of Life of Hypertensive Patients and Comparison of two Instruments of HRQOL Measure. Arq Bras Cardiol. 2012;98(5):442–51.
24. Sari A, Baroroh F. Kualitas Hidup Pasien Hipertensi Rawat Jalan di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta Dengan Terapi Kombinasi Angiotensin Reseptor Blocker dan Calcium Channel Blocker. J Sains dan Teknol Farm. 2017;19(Desember):6–10.
25. Fithria. Kualitas Hidup Penderita Hipertensi di Desa Lamceu Kecamatan Kuta Baro Kabupaten Aceh Besar. Idea Nurs J. 2011;62–9.
52
Cancer Therapy Combination Fluorouracil, Doxorubicin, and Cyclofosfamide.
27. Diener E, Suh EM, Lucas RE, Smith HL. Subjective well-being: Three Decades of Progress. Psychol Bull. 1999;125(2):276–302.
28. Bottomley A. The Cancer Patient and Quality of Life. Oncol J. 2002;7:120–5.
29. WHO. WHOQOL: Measuring Quality of Life. Psychol Med. 1997;(3):551– 8.
30. Setiati S, Harimurti K, Dewiasty E, Istanti R. Predictors and scoring system for health-related quality of life in an Indonesian community-dwelling elderly population.
31. Mcmurray JJ V, Anker SD, Auricchio A, Bo M. ESC Guidelines for The Diagnosis and Treatment of Acute and Chronic Heart Failure. Eur J Heart Fail. 2012;14:803–69.
32. Kranciukaite D, Rastenyte D. Measurement of Quality of Life in Stroke Patients. Medicina (Kaunas). 2006;42(9):709–16.
33. Zahran HS, Kobau R, Moriarty D, Zack M, Holt J, Donehoo R. Health-Related Quality of Life Surveillance — United States , 1993 – 2002. 2005;54:1–35.
34. Buck D, Jacoby A, Massey A, Ford G. Evaluation of Measures Used to Assess Quality of Life After Stroke. Am Hear Assoc. 2000;88(10):32–4. 35. Garin O, Ferrer M, Pont À, Rué M, Kotzeva A, Wiklund I, et al.
Disease-Specific Health-Related Quality of Life Questionnaires for Heart Failure: A Systematic Review with Meta-Analyses. Qual Life Res. 2009;18(1):71–85. 36. Harmaini F. Uji Keandalan dan Kesahihan Formulir EQ-5D untuk Mengukur Kualitas Hidup Terkait Kesehatan pada Usia Lanjut di RSUPNCM. 2006.
37. Hull A. Penyakit Jantung, Hipertensi, dan Nutrisi. Wendara A, editor. Jakarta: Pt. Bumi Aksara; 1993.
38. Service D of H and H. The Seventh Report of the Joint National Committe on Prevention, Detection, Evaluation, and Treatment of high Blood Pressure [Internet]. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). US: NIH Publication; 2004.
53 Jakarta: Depkes RI;
40. Muir BL. PhatoPhysiology An Introduction TonThe Mechanism of Disease. USA: John Wiley & Sons, Inc; 1980.
41. Patel C. Fighting Heart Disease: A Practical Self-help Guide to Prevention and Treatment. India: Thomson Press Limited; 1995.
42. VIkrant S, Tiwari S. Essential Hypertension – Pathogenesis and Pathophysiology. Journal, Indian Acad Clin Med. 2001;2(3).
43. Bullock BL. Pathophysiology Adaptations and Alteractions in Function. 4 th. USA: Lippincott - Raven Publishers; 1996.
44. Portman RJ. Pediatric Hypertension. New Jersey: Humana Press; 2004. 45. Black J., Hawks J. Medical Surgical Nursing. New York: Elsevier; 2005. 46. Qiu C, Williams MA, Leisenring WM, Sorensen TK, Frederick IO,
Dempsey JC, et al. Family History of Hypertension and Type 2 Diabetes in Relation to Preeclampsia Risk. Am Hear Assoc. 2003;41(3 I):408–13. 47. Bare B, Smeltzer S. Buku Ajar Keperawatan Medical Bedah I. Jakarta:
EGC; 2001.
48. Baziad A. Kontrasepsi Hormonal. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohario; 2002 p.
49. Haris S, Tambunan T. Hipertensi pada Sindrom Metabolik. Sari Pediatr. 2009;11(4):257–63.
50. Hahn D., Payne W. Medical surgical Nursing: Clinical Management for Positive Outcomes. St. Louis: Elsevier; 2005.
51. Depkes. Pedoman Teknis Penemuan dan Tatalaksana Hipertensi [Internet]. Jakarta: Depkes RI; 2013. 7-12 328.
52. WHO. Hypertension Control. 1999.
53. Kodim N. Analisis Kontekstual: Hubungan Lingkungan Sosiodemografi dengan Hipertensi yang tidak Terkendali pada Calon Jemaah Haji Indonesia. Universitas Indonesia; 2004.
54. Weber M., Schiffrin E., White W., Mann S, Lindolm L, Kenerson J. Clinical Practice Guidelines for The Management of Hypertension in The Community. J Am Soc Hypertens. 2014;53–63.
54
56. Depkes. Pharmaceutical Care untuk Penyakit Hipertensi. Jakarta: Depkes RI; 2006.
57. Traylor K, Gurgle H, Brockbank J. Antihypertensive Drugs. Side Eff Drugs Annu. 2018;40(January):263–7.
58. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society ofHypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925–38.
59. Ruilope LM, Coca A. The role of combination therapy in the treatment of hypertension. Blood Press. 1998;7(SUPPL. 1):22–6.
60. Sinha AD, Agarwal R. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD. Clin J Am Soc Nephrol. 2019;14(5):757–64.
61. Tedla YG, Bautista LE. Drug Side Effect Symptoms and Adherence to Antihypertensive Medication. Am J Hypertens. 2016;29(6):772–9.
62. Rahn KH. Principles of antihypertensive drug treatment. Am J Cardiol. 1990;65(14):82–4.
63. Ckd DOF, Graded N. Chapter 1: Definition and classification of CKD. Kidney Int Suppl [Internet]. 2013;3(1):19–62.
64. Stigant C, Stevens L, Levin A. Nephrology: 4. Strategies for the care of adults with chronic kidney disease. C Guid Nephrol Ser [Internet]. 2003;168(12):1553–60.
65. Ma Q, Zheng J, Zhang J, Dong Y. Three-dimensional numerical simulation of geosynthetic-reinforced and pile-supported embankment with coupling beams. J Huazhong Univ Sci Technol (Natural Sci Ed. 2011;39(10).
66. Raihan LN, Erwin, Dewi AP. Hipertensi Primer Pada Masyarakat Di Wilayah Kerja. Jom Psik. 2014;I(2):1–10.
67. Sari A. Puskesmas Mergangsan Yogyakarta Menggunakan Europan Quality of Life 5 Dimensions ( EQ5D ) Questionnaire dan Visual Analog Scale ( VAS ). J Ilm Ibnu Sina. 2017;2(1):1–12.
68. Hardati AT, Ahmad RA. Pengaruh aktivitas fisik terhadap kejadian hipertensi pada pekerja (Analisis data Riskesdas 2013). Ber Kedokt Masy. 2018;33(10):467.
55 Dunitz Ltd; 2002.
70. Tedesco MA, Di Salvo G, Caputo S, Natale F, Ratti G, Iarussi D, et al. Educational level and hypertension: How socioeconomic differences condition health care. J Hum Hypertens. 2001;15(10):727–31.
71. farida umul, Cahyani PW. Pola Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Rawat Inap Di Rsud Mardi Waluyo Blitar Bulan Juli-Desember Tahun 2016. J Wiyata Penelit Sains dan Kesehat
72. Koyanagi R, Hagiwara N, Yamaguchi J ichi, Kawada-Watanabe E, Haruta S, Takagi A, et al. Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: A subanalysis of the HIJ-CREATE study. J Cardiol
73. Pramono A, Sumariyono, Isbagio H. Reliability and validity of European Quality of Life 5 Dimension ( EQ-5D ) for measuring health-related quality of life in knee osteoarthritis patients at Cipto Mangunkusumo General Hospital. Indones J Rheumatol. 2010;02:19–25.
74. Nasim A, Haq N, Riaz S, Tahir M. Health Related Quality Of Life ( Hrqol ) -What It Is And How It Is It Is And How It Is Measured : Studies From The. 2018;(March).
75. Kyranou M, Paul SM, Dunn LB, Puntillo K, Aouizerat BE, Abrams G, et al. Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery.
76. Nilsson E. Aspects of health-related quality of life: Associations with psychological and biological factors, and use as patient reported outcome in routine health care [Internet]. Linköping University, Faculty of Health Sciences. 2012. 80
77. S S, Kalesaran A, Kandou G. The association between hypertension and quality of life among elderly : A population based comparison study with general population in Tomohon , Indonesia. Glob J Med Public Heal. 2017;6(6).
78. Oza BB, Patel BM, Malhotra SD, Patel VJ. Health related quality of life in hypertensive patients in a tertiary care teaching hospital. J Assoc Physicians India. 2014;62(OCT 2014):22–9.
79. Kitaoka M, Mitoma J, Asakura H, Anyenda OE, Nguyen TTT, Hamagishi T, et al. The relationship between hypertension and health-related quality of life: adjusted by chronic pain, chronic diseases, and life habits in the general middle-aged population in Japan. Environ Health Prev Med. Springer Japan; 2016;21(4):193–214.
56
80. Xu X, Rao Y, Shi Z, Liu L, Chen C, Zhao Y. Hypertension Impact on Health-Related Quality of Life: A Cross-Sectional Survey among Middle-Aged Adults in Chongqing, China. Int J Hypertens. 2016;2016:1–7.
81. Shapo L, Pomerleauv J, Mckee M. Epidemiology of hypertension and associated cardiovaskular risk factor. J Epidemiol Community Heal. 2003;57(9):734–9.
